Clinical Trial Update: Failed Endometrial Ablation Treatment With Implantable Progesterone (FEAT) Study [Phase 2]

View source ↗

Summary

The Phase 2 FEAT trial investigating endometrial ablation with an implantable progesterone device has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abnormal Uterine Bleeding
• Dysmenorrhea

Snippet

Sponsor: Saskatchewan Health Authority - Regina Area | Conditions: Abnormal Uterine Bleeding, Dysmenorrhea | Phase 2 | Status: WITHDRAWN